Cargando…
Inhibition of mTORC2/Akt signaling to enhance the therapeutic potential of CD8 T cells
Autores principales: | Zhang, Lianjun, Tschumi, Benjamin, Oberle, Susanne, Ruegg, Markus, Hall, Michael, Zehn, Dietmar, Mach, Jean-Pierre, Donda, Alena, Romero, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649477/ http://dx.doi.org/10.1186/2051-1426-3-S2-P330 |
Ejemplares similares
-
Tumor targeting of innate and adaptive immunity by the adoptive cell transfer of engineered T lymphocytes co-expressing iNKT and tumor-specific MHC-I TCRs
por: Tschumi, Benjamin O, et al.
Publicado: (2014) -
CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018) -
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
por: Ding, Xiaolei, et al.
Publicado: (2016) -
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
por: Corgnac, Stéphanie, et al.
Publicado: (2014) -
Correction to: CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018)